Those using GLP-1 medications solely for weight management (without diabetes) are not at risk for diabetic retinopathy progression, though they should report any visual symptoms promptly given the ongoing investigation of rare non-retinopathy eye events
When GLP-1 medications expire, the protein structure begins to degrade, potentially creating: Reduced effectiveness (youre not getting the blood sugar control or weight loss benefits) Increased side effects (nausea, vomiting could worsen) Potential immune reactions (your body might react to the degraded proteins) Red Flags: When Your GLP-1 Has Gone Rogue You dont always need a calendar to know when your medication has gone bad
The medication is working, so why push it
The effects of GLP-1 medications may not be permanent
Structured lifestyle modification programmes, as recommended by NICE guidance CG189, form the cornerstone of weight management for all patients, including those with Hashimoto's disease
Researchers study Orforglipron to evaluate GLP-1 receptor activation, receptor signaling behavior, small-molecule agonist design, and oral GLP-1 pathway models under controlled laboratory conditions
